Concepedia

Author

Ann Mohrbacher

University of Southern California

Also Known As

Ann M Mohrbacher, Ann M. Mohrbacher, Ann Mohrbacher

31

Publications

977

Citations

12

H-Index

25

Concepts

All Affiliations

University of Southern CaliforniaMemorial Sloan Kettering Cancer CenterRush University Medical CenterHackensack University Medical CenterUniversity of Michigan
AM

About

Ann Mohrbacher is an author at University of Southern California specializing in hematology, medicine, and health sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

532

2

Health Sciences

4

4

449

3

Biochemistry

1

1

31

4

Blood Transplantation

1

1

12

5

Cell Biology

1

1

12

Ann Mohrbacher

×

12

Publications

908

Citations

11

H-Index

YearCitations

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç,

The Lancet Oncology

2019

375

Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma

Robert M. Rifkin, Stephanie A. Gregory, Ann Mohrbacher,

Cancer

2006

131

Pharmacokinetics-Based Integration of Multiple Doses of Intravenous Pegaspargase in a Pediatric Regimen for Adults With Newly Diagnosed Acute Lymphoblastic Leukemia

Dan Douer, Ibrahim Aldoss, Matthew A. Lunning,

Journal of Clinical Oncology

2014

119

Toxicity profile of repeated doses of <scp>PEG</scp>‐asparaginase incorporated into a pediatric‐type regimen for adult acute lymphoblastic leukemia

Ibrahim Aldoss, Dan Douer, Carolyn E. Behrendt,

European Journal Of Haematology

2015

83

HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia

Mei Guo, Nelson J. Chao, Jianyong Li,

JAMA Oncology

2017

46

Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: A California Cancer Consortium Trial

Ann Mohrbacher, Allen S. Yang, Susan Groshen,

Clinical Cancer Research

2017

35

Adding ascorbic acid to arsenic trioxide produces limited benefit in patients with acute myeloid leukemia excluding acute promyelocytic leukemia

Ibrahin Aldoss, Lisa Mark, Janice Vrona,

Annals of Hematology

2014

31

Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent doses

Patrick W. Burke, Ibrahim Aldoss, Matthew A. Lunning,

Leukemia Research

2018

31

Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study

Swaminathan P. Iyer, Auris Huen, Weiyun Z. Ai,

Haematologica

2023

19

Safety and Efficacy of Tenalisib Given in Combination with Romidepsin in Patients with Relapsed/Refractory T-Cell Lymphoma: Final Results from a Phase I/II Open Label Multi-Center Study

Swaminathan P. Iyer, Auris Huen, Weiyun Z. Ai,

Blood

2021

15

Page 1